Brief: Algorae Pharmaceuticals Signs Exclusive License Agreement With Sakar
22/09/2025 23:56
Sept 23 (Reuters) - Algorae Pharmaceuticals Ltd 1AI.AX: ALGORAE SIGNS EXCLUSIVE LICENSE AGREEMENT WITH SAKAR DEAL FOR LAUNCHING 5 GENERIC ONCOLOGY MEDICINES INTO AUSTRALIAN, NZ MARKETS Further company coverage: 1AI.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Algorae Pharmaceuticals
See all newsAlgorae Pharmaceuticals rises on Australian distribution deal with India's Umedica
Brief: Algorae Pharmaceuticals Executes Licence & Supply Agreement With Umedica
Australia's Algorae Pharmaceuticals gains on Peter MacCallum Cancer Centre partnership
Brief: Algorae Pharmaceuticals Partners With Peter Maccallum Cancer Centre
Brief: Algorae Pharmaceuticals Named Launch Partner In Sovereign Ai Infrastructure Initiative